BB Biotech’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $239M | Sell |
1,300,000
-70,445
| -5% | -$13M | 6.01% | 4 |
|
|
2018
Q4 | $227M | Hold |
1,370,445
| – | – | 7.28% | 4 |
|
|
2018
Q3 | $264M | Sell |
1,370,445
-30,000
| -2% | -$5.78M | 6.99% | 4 |
|
|
2018
Q2 | $238M | Sell |
1,400,445
-75,000
| -5% | -$12.7M | 6.87% | 5 |
|
|
2018
Q1 | $240M | Hold |
1,475,445
| – | – | 6.65% | 5 |
|
|
2017
Q4 | $221M | Hold |
1,475,445
| – | – | 6.23% | 5 |
|
|
2017
Q3 | $224M | Hold |
1,475,445
| – | – | 6.21% | 5 |
|
|
2017
Q2 | $190M | Buy |
1,475,445
+20,000
| +1% | +$2.58M | 5.81% | 6 |
|
|
2017
Q1 | $159M | Buy |
1,455,445
+40,000
| +3% | +$4.37M | 5.21% | 7 |
|
|
2016
Q4 | $104M | Hold |
1,415,445
| – | – | 3.86% | 10 |
|
|
2016
Q3 | $123M | Hold |
1,415,445
| – | – | 4.34% | 9 |
|
|
2016
Q2 | $122M | Buy |
1,415,445
+50,000
| +4% | +$4.3M | 4.81% | 8 |
|
|
2016
Q1 | $109M | Hold |
1,365,445
| – | – | 4.31% | 9 |
|
|
2015
Q4 | $172M | Hold |
1,365,445
| – | – | 4.84% | 8 |
|
|
2015
Q3 | $142M | Buy |
1,365,445
+31,000
| +2% | +$3.23M | 4.51% | 8 |
|
|
2015
Q2 | $165M | Hold |
1,334,445
| – | – | 4.47% | 7 |
|
|
2015
Q1 | $157M | Sell |
1,334,445
-20,000
| -1% | -$2.36M | 4.69% | 7 |
|
|
2014
Q4 | $161M | Hold |
1,354,445
| – | – | 5.21% | 6 |
|
|
2014
Q3 | $152M | Sell |
1,354,445
-50,000
| -4% | -$5.62M | 6.19% | 5 |
|
|
2014
Q2 | $133M | Hold |
1,404,445
| – | – | 6.32% | 5 |
|
|
2014
Q1 | $99.3M | Hold |
1,404,445
| – | – | 5.12% | 6 |
|
|
2013
Q4 | $104M | Hold |
1,404,445
| – | – | 5.58% | 5 |
|
|
2013
Q3 | $106M | Hold |
1,404,445
| – | – | 5.79% | 5 |
|
|
2013
Q2 | $112M | Buy |
+1,404,445
| New | +$112M | 8.1% | 5 |
|